AkVida GmbH (batch control and batch release; bulk manufacturing, primary and secondary packaging, batch control)
UkraineAll drugs from this manufacturer
-
The drug is used to treat advanced colorectal cancer. It may be used either alone or in combination with other drugs (e.g., 5-fluorouracil, folinic acid, cetuximab, bevacizumab, or capecitabine) depending on the stage of the disease and previous treatment.
Dosage form: concentrate for infusion solution
Active substance Dosage irinotecan 17.33 mg/ml ATC: L01CE02